Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1817753
Max Phase: Preclinical
Molecular Formula: C42H65N13O11S2
Molecular Weight: 992.20
Molecule Type: Protein
Associated Items:
ID: ALA1817753
Max Phase: Preclinical
Molecular Formula: C42H65N13O11S2
Molecular Weight: 992.20
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O
Standard InChI: InChI=1S/C42H65N13O11S2/c1-4-22(2)34-41(65)52-28(18-32(45)57)37(61)51-27(17-31(44)56)38(62)53-29(21-68-67-20-24(43)35(59)50-26(39(63)54-34)16-23-10-6-5-7-11-23)42(66)55-15-9-13-30(55)40(64)49-25(12-8-14-47-3)36(60)48-19-33(46)58/h5-7,10-11,22,24-30,34,47H,4,8-9,12-21,43H2,1-3H3,(H2,44,56)(H2,45,57)(H2,46,58)(H,48,60)(H,49,64)(H,50,59)(H,51,61)(H,52,65)(H,53,62)(H,54,63)/t22-,24-,25-,26-,27-,28-,29-,30-,34-/m0/s1
Standard InChI Key: XSBKPDFLYYAOGS-OVCMMVBBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 992.20 | Molecular Weight (Monoisotopic): 991.4368 | AlogP: -4.75 | #Rotatable Bonds: 18 |
Polar Surface Area: 391.33 | Molecular Species: BASE | HBA: 15 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 24 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.31 | CX Basic pKa: 9.92 | CX LogP: -6.45 | CX LogD: -9.15 |
Aromatic Rings: 1 | Heavy Atoms: 68 | QED Weighted: 0.05 | Np Likeness Score: 0.37 |
1. Wisniewski K, Galyean R, Tariga H, Alagarsamy S, Croston G, Heitzmann J, Kohan A, Wisniewska H, Laporte R, Rivière PJ, Schteingart CD.. (2011) New, potent, selective, and short-acting peptidic V1a receptor agonists., 54 (13): [PMID:21688787] [10.1021/jm200278m] |
Source(1):